Replies to post #41 on Alexion Pharmaceuticals, Inc. (ALXN)

[surf1944]

An Uncommon Sense Growth Strategy For Bull And Bear Markets

looks like a short sell listing

http://seekingalpha.com/article/288817-an-uncommon-sense-growth-strategy-for-bull-and-bear-markets?source=yahoo

[PoemStone]

surf1944. ALXN. New Drug Approval:
Soliris (eculizumab) Approved by FDA for All Patients with Atypical Hemolytic Uremic Syndrome (aHUS)
http://www.drugs.com/newdrugs/soliris-eculizumab-approved-fda-all-patients-atypical-hemolytic-uremic-syndrome-ahus-2872.html